Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate (Q46120241)

http://europepmc.org/abstract/PMC/5167782

19 December 2017

title

Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate (English)

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

15

Peter G Schultz

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

author name string

Shan Yu

1

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Aaron D Pearson

2

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Reyna Kv Lim

3

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

David T Rodgers

4

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Sijia Li

5

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Holly B Parker

6

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Meredith Weglarz

7

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Eric N Hampton

8

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Michael J Bollong

9

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Jiayin Shen

10

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Claudio Zambaldo

11

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Danling Wang

12

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Ashley K Woods

13

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Timothy M Wright

14

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Stephanie A Kazane

16

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Travis S Young

17

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

Matthew S Tremblay

18

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

publication date

12 October 2016

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

published in

Molecular Therapy

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

volume

24

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

issue

12

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

page(s)

2078-2089

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

cites work

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug Conjugate

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

An immunosuppressive antibody-drug conjugate

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Advances in targeting cyclic nucleotide phosphodiesterases

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Safety and tolerability of the inhaled phosphodiesterase 4 inhibitor GSK256066 in moderate COPD.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Phosphodiesterase 4 inhibitors in inflammatory bowel disease: a comprehensive review

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Monoclonal antibodies and progressive multifocal leukoencephalopathy

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

PDE4 inhibitors: current status

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Cell killing by antibody-drug conjugates

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab (Raptiva): mechanisms of action.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Tissue distribution and receptor-mediated clearance of anti-CD11a antibody in mice

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Pica in mice as a new model for the study of emesis

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5167782

Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD

15 August 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/27731313

12 December 2020

In Vivo Characterization of GSK256066, a High-Affinity Inhaled Phosphodiesterase 4 Inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/27731313

12 December 2020

GSK256066, an Exceptionally High-Affinity and Selective Inhibitor of Phosphodiesterase 4 Suitable for Administration by Inhalation: In Vitro, Kinetic, and In Vivo Characterization

1 reference

https://pubmed.ncbi.nlm.nih.gov/27731313

12 December 2020

Antibody–drug conjugates for cancer: poised to deliver?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27731313

12 December 2020

The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/27731313

12 December 2020

Efalizumab in the treatment of psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27731313

12 December 2020

Identifiers

DOI

10.1038/MT.2016.175

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

PMC publication ID

5167782

1 reference

http://europepmc.org/abstract/PMC/5167782

19 December 2017

PubMed publication ID

27731313

1 reference